Monday, October 15, 2018
 
 
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
FDA Approves US WorldMeds' LUCEMYRA™ (lofexidine) After Priority Review for the Management of Opioid Withdrawal Symptoms
LUCEMYRA is the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptomsIn clinical trials, LUCEMYRA significantly reduced the severity of withdrawal symptoms compar...
(May 16, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,Sexual,healthcare,Surgery,Medication,Science,Medical,Adults,Family,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines